Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2390 (LINC02390)

Target
LINC02390
Molecular classification
Other (classified as a "long intergenic non-coding RNA" or lincRNA, which is a subclass of long non-coding RNAs)
01

Overview

Long intergenic non-protein coding RNA 2390 (LINC02390) is a human gene that encodes a transcript classified as a **long intergenic non-coding RNA (lincRNA)**, which means its RNA product is longer than 200 nucleotides, does not overlap with protein-coding genes, and does not encode a functional protein[1][3][5]. LincRNAs such as LINC02390 can regulate gene expression through multiple mechanisms, including chromatin remodeling, acting as enhancers, influencing transcription in cis or trans, and interacting with RNA or protein complexes[3][7]. LINC02390 is not classified as a therapeutic target (i.e., receptor, enzyme, transporter), but it may play roles in fine-tuning gene regulation and is part of the growing catalog of non-coding RNAs potentially relevant for disease research or biomarker discovery[1][3][7]. There is currently **no direct evidence** linking LINC02390 to drugs, mechanisms of action, or well-validated roles in disease, and it is primarily of interest as a non-coding regulatory RNA.

Other names
LINC02390long intergenic non-protein coding RNA 2390
02

Biological functions

Regulation of neighboring gene expression (cis/trans)Chromatin remodeling and gene transcription regulationPotential enhancer-like activity
03

Disease associations

Other (while lincRNAs have been implicated in cancer, neurological diseases, and as potential biomarkers, there is no direct evidence for LINC02390 specifically)
04

Biomarkers

null (lincRNAs in general are emerging as biomarkers, but none specifically validated for LINC02390)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2390 (LINC02390).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2390 (LINC02390).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call